Latest News about TAK
Recent news which mentions TAK
From Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
December 07, 2023
Tickers
TAK
From Benzinga
Peering Into Takeda Pharmaceutical's Recent Short Interest
November 21, 2023
Tickers
TAK
From Benzinga
Why Is Neurocrine Biosciences Stock Trading Lower Today?
November 10, 2023
From Benzinga
Neurocrine Biosciences shares drop as trial failures may ‘stunt momentum,’ analysts say
November 10, 2023
From MarketWatch
Back To Back FDA Approval For Takeda Within Two Days, Secures Green Signal For Rare Blood Disorder Therapy
November 10, 2023
Tickers
TAK
From Benzinga
3 Promising Biotech Stocks Flying Under the Radar
November 08, 2023
From InvestorPlace
Looking Into Takeda Pharmaceutical's Recent Short Interest
November 03, 2023
Tickers
TAK
From Benzinga
Earnings Scheduled For October 26, 2023
October 26, 2023
From Benzinga
A Look Into Takeda Pharmaceutical Inc's Price Over Earnings
October 19, 2023
Tickers
TAK
From Benzinga
Takeda's Crohn's Disease Fistulas Candidates Fall Short In Mid-Stage Study, Settles Tax Dispute With Irish Revenue Commissioners
October 18, 2023
From Benzinga
Looking Into Takeda Pharmaceutical's Recent Short Interest
October 11, 2023
Tickers
TAK
From Benzinga
A Look Into Takeda Pharmaceutical Inc's Price Over Earnings
October 04, 2023
Tickers
TAK
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 02, 2023
From Benzinga
Can Japan's Economy Continue To Blossom If Bank of Japan Raises Rates? Apparently So.
October 02, 2023
From Benzinga
Morphic Therapeutic's Stock Plunges On Monday - Here's Why?
September 25, 2023
From Benzinga
Looking Into Takeda Pharmaceutical's Recent Short Interest
September 25, 2023
Tickers
TAK
From Benzinga
Top 4 Health Care Stocks That Should Keep You Up At Night
September 21, 2023
From Benzinga
From Benzinga
Ovarian Cancer Player ImmunoGen Can Potentially Be Attractive M&A Target: JP Morgan
September 13, 2023
From Benzinga
(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
September 08, 2023
Tickers
TAK
From Benzinga
From Benzinga
From Motley Fool
2 Ultra-Cheap High-Yield Dividend Stocks to Buy Now
August 23, 2023
From Motley Fool
Why Are Poseida Therapeutics Shares Moving Higher Today?
August 07, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.